Advanced in Primary T Cell Immunodeficiency

Arnaud Y. Petit

Paris, FR 
Advanced in Primary T Cell Immunodeficiency
Paris, FR 
OverviewLocationsClinical Research

Overview

Arnaud Petit practices in Paris, France. Mr. Petit is rated as an Advanced expert by MediFind in the treatment of Primary T Cell Immunodeficiency. His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Acute Megakaryoblastic Leukemia, Leukemia, and Acute Myeloid Leukemia (AML).

His clinical research consists of co-authoring 148 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Primary T Cell Immunodeficiency.

Gender
Male

Locations

Paris, France
Other Locations
Montpellier, France
Boulogne-billancourt, France
Bobigny, France
Villejuif, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 1, Multicentre, Open-Label, Dose-Escalation and Cohort Expansion Study of Niraparib and Dostarlimab in Paediatric Patients With Recurrent or Refractory Solid Tumours
A Phase 1, Multicentre, Open-Label, Dose-Escalation and Cohort Expansion Study of Niraparib and Dostarlimab in Paediatric Patients With Recurrent or Refractory Solid Tumours
Enrollment Status: Terminated
Publish Date: July 16, 2025
Intervention Type: Drug
Study Phase: Phase 1
Pan-genome Analysis of Neuroblastoma by Comparative Genomic Hybridization and Correlation With Pathology for the Diagnostic and the Prognostic Classification
Pan-genome Analysis of Neuroblastoma by Comparative Genomic Hybridization and Correlation With Pathology for the Diagnostic and the Prognostic Classification
Enrollment Status: Completed
Publish Date: December 01, 2023
Intervention Type: Procedure
Study Phase: Not Applicable
View 1 Less Clinical Trial

148 Total Publications

Prognostic impact of the PredicT-ALL classifier in the AALL0434 trial: a model combining NGS, MRD, and WBC at diagnosis.
Prognostic impact of the PredicT-ALL classifier in the AALL0434 trial: a model combining NGS, MRD, and WBC at diagnosis.
Journal: Blood advances
Published: June 09, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Petit's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 30 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile